Department of Chemical Engineering, University of Puerto Rico-Mayagüez, Call Box 9000, Mayagüez, Puerto Rico 00681-9000, United States.
Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin 53706, United States.
ACS Biomater Sci Eng. 2021 Jun 14;7(6):2430-2443. doi: 10.1021/acsbiomaterials.0c01803. Epub 2021 Mar 10.
The fibril orientation of type I collagen has been shown to contribute to tumor invasion and metabolic changes. Yet, there is limited information about its impact on tumor cells' behavior in a restrictive growth environment. Restrictive growth environments are generated by the inhibition of a proliferation stimulus during therapy or as an inflammatory response to suppress tumor expansion. In this study, the impact of a type I collagen matrix orientation and fibrous architecture on cell proliferation and response to estrogen receptor (ER) therapy were examined using estrogen-dependent breast tumor cells (MCF-7 and T-47D) cultured in a hormone-restricted environment. The use of hormone-free culture media, as well as pharmacological inhibitors of ER, Tamoxifen, and Fulvestrant, were investigated as hormone restrictive conditions. Examination of cultures at 72 h showed that tumor cell proliferation was significantly stimulated (1.8-fold) in the absence of hormones on collagen fibrous substrates, but not on polycaprolactone fibrous substrates of equivalent orientation. ER inhibitors did not suppress cell proliferation on collagen fibrous substrates. The examination of reporter cells for ER signaling showed a lack of activity, thus confirming a shift toward an ER-independent proliferation mechanism. Examination of two selective inhibitors of α2β1 and α1β1 integrins showed that cell proliferation is suppressed in the presence of the α2β1 integrin inhibitor only, thereby indicating that the observed changes in tumor cell behavior are caused by a combination of integrin signaling and/or an intrinsic structural motif that is uniquely present in the collagen fibrils. Adjacent coculture studies on collagen substrates showed that tumor cells on collagen can stimulate the proliferation of cells on tissue culture plastic through soluble factors. The magnitude of this effect correlated with the increased surface anisotropy of the substrate. This sensing in fibril orientation was further supported by a differential expression pattern of secreted proteins that were identified on random and aligned orientation substrates. Overall, this study shows a new role for electrospun collagen I fibrous substrates by supporting a shift toward an ER-independent tumor cell proliferation mechanism in ER+ breast tumor cells.
I 型胶原的纤维取向已被证明有助于肿瘤的侵袭和代谢变化。然而,关于其在限制生长环境中对肿瘤细胞行为的影响的信息有限。限制生长环境是通过在治疗过程中抑制增殖刺激或作为抑制肿瘤扩张的炎症反应产生的。在这项研究中,使用依赖于雌激素的乳腺癌细胞(MCF-7 和 T-47D)在激素受限环境中培养,研究了 I 型胶原基质取向和纤维结构对细胞增殖和雌激素受体(ER)治疗反应的影响。使用无激素培养基以及 ER 的药理学抑制剂他莫昔芬和氟维司群作为激素限制条件进行了研究。在 72 小时检查培养物时发现,在无激素的情况下,肿瘤细胞在胶原纤维基质上的增殖显著增加(1.8 倍),但在具有相同取向的聚己内酯纤维基质上则没有。ER 抑制剂不能抑制胶原纤维基质上的细胞增殖。对 ER 信号的报告细胞进行检查表明,没有活性,从而证实了向 ER 独立增殖机制的转变。对两种α2β1 和α1β1 整合素选择性抑制剂的检查表明,只有在存在α2β1 整合素抑制剂的情况下,细胞增殖才受到抑制,从而表明观察到的肿瘤细胞行为变化是由整合素信号和/或独特存在于胶原纤维中的内在结构基序的组合引起的。在胶原底物上进行的相邻共培养研究表明,在胶原上的肿瘤细胞可以通过可溶性因子刺激组织培养塑料上的细胞增殖。这种效应的大小与底物表面各向异性的增加相关。这种对纤维取向的感知还得到了在随机和定向取向基质上鉴定的分泌蛋白的差异表达模式的支持。总的来说,这项研究通过支持 ER+乳腺癌细胞中向 ER 独立的肿瘤细胞增殖机制的转变,为静电纺丝胶原 I 纤维基质提供了新的作用。